BGS vs LWAY

BGS has a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite deeply depressed valuation multiples—Price/Book of 0.75 and Price/Sales of 0.19—the company is unprofitable on a net basis with a -13.61% profit margin and an alarming -40.86% ROE. The dividend yield of 17.76% is unsustainable given a 333.33% payout ratio, and insider selling, weak earnings surprises, and negative revenue growth further undermine confidence. While recent EPS growth appears strong, it stems from a low base after prior losses, and the stock trades below analyst target prices, signaling limited upside.

LWAY exhibits a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health despite a clean balance sheet. The stock is trading at a severe premium to both its Graham Number ($10.62) and Intrinsic Value ($6.23), suggesting the current price of $24.40 is speculative. While revenue growth is strong at 18%, consistent earnings misses and aggressive insider selling signal a lack of confidence in the current valuation.